Home › Cancro del polmone non a piccole cellule › Rhode Island › Providence
Studi clinici su Cancro del polmone non a piccole cellule a Providence, RI
12 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Providence e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Rhode Island Hospital, Providence
- Roger Williams Medical Center, Providence
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 1/2
- Research Site, Providence
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
In reclutamentoFase 1/2
- Rhode Island Hospital, East Providence · a 2 mi di distanza
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- Lifespan Cancer Institute, Providence
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
In reclutamentoFase 2
- Rhode Island Hospital, Providence
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
In reclutamentoFase 3
- Rhode Island Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
In reclutamentoFase 1/2
- Women and Infants Hospital of Rhode Island, Providence
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
In reclutamentoFase 1
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
In reclutamentoFase 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Providence
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
In reclutamentoFase 2
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
In reclutamentoStudio osservazionale
- Rhode Island Hospital, Brown University, Providence
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Altri studi a Providence
- Cancro ovarico15 studi
- Cancro dell'endometrio14 studi
- Obesità14 studi
- Cancro (tutti i tipi)12 studi
- Malattia di Crohn12 studi
- Colite ulcerosa11 studi
- Cancro al seno11 studi
- Leucemia mieloide acuta10 studi
- Cancro metastatico9 studi
- Sovrappeso9 studi
- Morbo di Alzheimer8 studi
- Disturbo da uso di alcol (AUD)8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.